scholarly article | Q13442814 |
P2093 | author name string | Aditi Bhargava | |
Min Liao | |||
Burcu Hasdemir | |||
Matthew S Clifton | |||
Jen Chang | |||
Julia H Brooks | |||
Melanie R Adams | |||
P2860 | cites work | Endothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and beta-arrestins | Q24301478 |
Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa | Q28142293 | ||
Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma | Q28214269 | ||
Human lymphocytes produce urocortin, but not corticotropin-releasing hormone | Q28262079 | ||
Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain | Q28273349 | ||
Local secretion of urocortin 1 promotes microvascular permeability during lipopolysaccharide-induced inflammation | Q28564845 | ||
Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-kappaB activation | Q28573704 | ||
Role of calcitonin receptor-like receptor in colonic motility and inflammation | Q28582321 | ||
Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets | Q30502566 | ||
Corticotropin releasing hormone--a GPCR drug target | Q33271151 | ||
Differential actions of urocortins on neurons of the myenteric division of the enteric nervous system in guinea pig distal colon | Q33661095 | ||
Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum | Q33836192 | ||
Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain | Q33866863 | ||
Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis | Q33905709 | ||
Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization | Q34361096 | ||
Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling | Q35213474 | ||
CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats | Q35761024 | ||
Urocortins and the regulation of gastrointestinal motor function and visceral pain | Q35914475 | ||
Localization and physiological roles of urocortin | Q35914477 | ||
Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha. | Q35954148 | ||
Stress and the gastrointestinal tract | Q36058948 | ||
Urocortin 2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis | Q37032269 | ||
The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family | Q37279430 | ||
Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response | Q38623682 | ||
Urocortin induces interleukin-6 gene expression via cyclooxygenase-2 activity in aortic smooth muscle cells | Q40267271 | ||
Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1. | Q40327323 | ||
Recycling and resensitization of the neurokinin 1 receptor. Influence of agonist concentration and Rab GTPases. | Q40558816 | ||
Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides | Q40608234 | ||
Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq- | Q40837517 | ||
Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids | Q41704808 | ||
Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease | Q41980597 | ||
A reproducible grading scale for histological assessment of inflammation in ulcerative colitis | Q42130317 | ||
Distribution of urocortin in the rat's gastrointestinal tract and its colocalization with tyrosine hydroxylase. | Q42165136 | ||
Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation | Q42501072 | ||
Urocortin increases IL-4 and IL-10 secretion and reverses LPS-induced TNF-alpha release from human trophoblast primary cells | Q43287045 | ||
The Edinger-Westphal-lateral septum urocortin pathway and its relationship to alcohol consumption. | Q44376624 | ||
Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity. | Q44681184 | ||
Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity | Q45225797 | ||
Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation | Q46233130 | ||
Distribution of urocortin 2 in various tissues of the rat. | Q46700598 | ||
CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon | Q47261340 | ||
Urocortin mRNA is expressed in the enteric nervous system of the rat. | Q48167496 | ||
Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors | Q48278195 | ||
Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon | Q48571055 | ||
Assay method for myeloperoxidase in human polymorphonuclear leukocytes | Q53558668 | ||
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease. | Q54775460 | ||
Urocortin 1 in Colonic Mucosa in Patients with Ulcerative Colitis | Q60713422 | ||
Hapten-induced model of chronic inflammation and ulceration in the rat colon | Q69942171 | ||
Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity | Q74494205 | ||
Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway | Q74795531 | ||
Urocortin in human gastric mucosa: relationship to inflammatory activity | Q78767932 | ||
Genetic deletion of JNK1 and JNK2 aggravates the DSS-induced colitis in mice | Q79965155 | ||
Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2 | Q80959647 | ||
P433 | issue | 5 | |
P921 | main subject | colitis | Q2453464 |
P304 | page(s) | G884-94 | |
P577 | publication date | 2011-02-17 | |
P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
P1476 | title | Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2 | |
P478 | volume | 300 |
Q43491697 | Actin cytoskeleton-dependent regulation of corticotropin-releasing factor receptor heteromers |
Q50077577 | Activation of corticotropin-releasing factor receptor 1 aggravates dextran sodium sulphate-induced colitis in mice by promoting M1 macrophage polarization |
Q37124646 | Corticotropin-Releasing Factor and Toll-Like Receptor Gene Expression Is Associated with Low-Grade Inflammation in Irritable Bowel Syndrome Patients with Depression. |
Q35903549 | Corticotropin-Releasing Hormone Receptor 2 Gene Variants in Irritable Bowel Syndrome |
Q37100274 | Corticotropin-releasing factor receptor 2 mediates sex-specific cellular stress responses |
Q36699277 | Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis |
Q89976009 | Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology |
Q36505484 | Endogenous CRF in rat large intestine mediates motor and secretory responses to stress |
Q35891329 | Endothelin-converting enzyme-1 actions determine differential trafficking and signaling of corticotropin-releasing factor receptor 1 at high agonist concentrations |
Q58759929 | Gastric corticotropin-releasing factor influences mast cell infiltration in a rat model of functional dyspepsia |
Q41191062 | Involvement of CRF2 signaling in enterocyte differentiation. |
Q34882241 | Multi-facets of Corticotropin-releasing Factor in Modulating Inflammation and Angiogenesis |
Q37492012 | Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions |
Q64243167 | Plasma Corticotropin-Releasing Factor Receptors and B7-2⁺ Extracellular Vesicles in Blood Correlate with Irritable Bowel Syndrome Disease Severity |
Q92113211 | Protective effects of urocortin 2 against caerulein-induced acute pancreatitis |
Q37071838 | Sex- and corticotropin-releasing factor receptor 2- dependent actions of urocortin 1 during inflammation |
Q34804743 | Stress-Derived Corticotropin Releasing Factor Breaches Epithelial Endotoxin Tolerance |
Q33553871 | Urocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talk |
Q36698796 | Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect |
Q34240005 | Urocortins and CRF type 2 receptor isoforms expression in the rat stomach are regulated by endotoxin: role in the modulation of delayed gastric emptying |
Q90488283 | Urocortins in the mammalian endocrine system |
Search more.